Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
NCT04411667
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Sars-CoV2
Interventions
DRUG:
Octagam
Sponsor
George Sakoulas, MD
Collaborators
[object Object]